Page 5 - Therapeutic Development Programs News Today

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research note released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.09 on Monday. Navidea Biopharmaceuticals has a one year low of $0.07 and a one year […]

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Up 7.9 % NYSEAMERICAN:NAVB opened at $0.09 on Friday. The stock’s fifty day moving average is $0.17 and its two-hundred […]

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Price Performance Navidea Biopharmaceuticals Company Profile (Get Rating) Navidea Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) and Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Earnings & Valuation This table compares Alpha Teknova and […]

Equities researchers at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the stock. Shares of NAVB stock opened at $0.69 on Friday. The firm has a 50 day moving average of $0.81. Navidea […]

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and Heska (NASDAQ:HSKA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Institutional and Insider Ownership 5.6% of Navidea Biopharmaceuticals shares are […]

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and VolitionRx (NYSE:VNRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings. Profitability This table compares Navidea Biopharmaceuticals and VolitionRx’s net margins, […]

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and StageZero Life Sciences (OTCMKTS:SZLSF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Risk & Volatility Navidea Biopharmaceuticals has a beta […]

/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...

/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...